Fifth Third Bancorp’s ClearPoint Neuro CLPT Stock Holding History

Fifth Third Bancorp’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50	Closed	-$251	–	2521
2023 Q3	$251	Hold	50	–	–	﹤0.01%	2544
2023 Q2	$362	Hold	50	–	–	﹤0.01%	2571
2023 Q1	$422	Hold	50	–	–	﹤0.01%	2715
2022 Q4	$424	Hold	50	–	–	﹤0.01%	2608
2022 Q3	$1K	Hold	50	–	–	﹤0.01%	2522
2022 Q2	$1K	Hold	50	–	–	﹤0.01%	2506
2022 Q1	$1K	Hold	50	–	–	﹤0.01%	2592
2021 Q4	$1K	Hold	50	–	–	﹤0.01%	2601
2021 Q3	$1K	Hold	50	–	–	﹤0.01%	2551
2021 Q2	$1K	Hold	50	–	–	﹤0.01%	2373
2021 Q1	$1K	Hold	50	–	–	﹤0.01%	2354
2020 Q4	$1K	Hold	50	–	–	﹤0.01%	2272
2020 Q3	$0	Hold	50	–	–	﹤0.01%	2287
2020 Q2	$0	Hold	50	–	–	﹤0.01%	2094
2020 Q1	$0	Hold	50	–	–	﹤0.01%	2139
2019 Q4	$0	Hold	50	–	–	﹤0.01%	2223
2019 Q3	$0	Buy	+50	New	+$205	﹤0.01%	2191

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fifth Third Bancorp's CLPT Position: Q4 2023 in Review

Fifth Third Bancorp sold out of ClearPoint Neuro (CLPT) in Q4 2023, closing a stake of 50 shares — an estimated $251 sold.

Fifth Third Bancorp first reported a position in CLPT in Q3 2019 and held it in 17 quarters. The position peaked at $1K in Q3 2022. 71 funds tracked by Wall St. Rank hold CLPT as of Q4 2023.

Fifth Third Bancorp reported no remaining ClearPoint Neuro position as of Q4 2023 after selling out during the quarter.
Fifth Third Bancorp sold 50 ClearPoint Neuro shares in Q4 2023, an estimated $251.
Fifth Third Bancorp first reported a position in ClearPoint Neuro in Q3 2019 and held it in 17 quarters.
Fifth Third Bancorp's ClearPoint Neuro position peaked at $1K in Q3 2022.
71 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2023.

Based on Fifth Third Bancorp's 13F filing for Q4 2023, filed 19 Jan 2024.